Scholarlink

Background <p>The exact pathogenesis of idiopathic pulmonary fibrosis (IPF) is unknown, but B and T cells, as part of the adaptive immune system, may play a role. Our aim was to immunohistochemically characterize B and T cells in fibrotic lung tissue and to study whether clinical features were associated with the numbers of cells.</p> Methods <p>We characterized immunohistochemically the expression of CD20 (a B-cell marker) and CD3 (a T-cell marker) in cells from surgical lung biopsies of patients with IPF (<i>N</i> = 34) and familial pulmonary fibrosis (FPF, <i>N</i> = 16), as well as in noncancerous control tissues from patients who had undergone lung cancer surgery (<i>N</i> = 11).</p> Results <p>CD20 was expressed in lymphoid cells occurring in aggregates often located near fibroblast foci. In contrast, CD3 expressions was observed in groups of cells and as scattered single cells. The expression of CD20 was higher in patients with IPF than in those with FPF or in the controls. CD3 expression was higher in the patients with IPF and FPF than in the controls. CD20 and CD3 expressions were lower in smokers than in non-smokers or ex-smokers. Higher CD20 expression was associated with a higher forced vital capacity (FVC) in patients with IPF, whereas a high number of T cells was associated with lower FVC in patients with FPF.</p> Conclusions <p>Differences were evident between FPF and IPF regarding the expressions of CD20 and CD3. The associations of B and T cells with smoking and lung function are novel observations that merit further investigation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

B and T cells in lung tissue are associated with smoking and forced vital capacity in idiopathic pulmonary fibrosis and familial pulmonary fibrosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月25日

查看全文
  • Hanna Jaula,
  • Mervi Kreus,
  • Anne Heikkinen,
  • Johanna Leppänen,
  • Elisa Lappi-Blanco,
  • Hannu Vähänikkilä,
  • Terttu Harju,
  • Riitta Kaarteenaho

摘要

Background

The exact pathogenesis of idiopathic pulmonary fibrosis (IPF) is unknown, but B and T cells, as part of the adaptive immune system, may play a role. Our aim was to immunohistochemically characterize B and T cells in fibrotic lung tissue and to study whether clinical features were associated with the numbers of cells.

Methods

We characterized immunohistochemically the expression of CD20 (a B-cell marker) and CD3 (a T-cell marker) in cells from surgical lung biopsies of patients with IPF (N = 34) and familial pulmonary fibrosis (FPF, N = 16), as well as in noncancerous control tissues from patients who had undergone lung cancer surgery (N = 11).

Results

CD20 was expressed in lymphoid cells occurring in aggregates often located near fibroblast foci. In contrast, CD3 expressions was observed in groups of cells and as scattered single cells. The expression of CD20 was higher in patients with IPF than in those with FPF or in the controls. CD3 expression was higher in the patients with IPF and FPF than in the controls. CD20 and CD3 expressions were lower in smokers than in non-smokers or ex-smokers. Higher CD20 expression was associated with a higher forced vital capacity (FVC) in patients with IPF, whereas a high number of T cells was associated with lower FVC in patients with FPF.

Conclusions

Differences were evident between FPF and IPF regarding the expressions of CD20 and CD3. The associations of B and T cells with smoking and lung function are novel observations that merit further investigation.